IN2014KN01211A - - Google Patents

Info

Publication number
IN2014KN01211A
IN2014KN01211A IN1211KON2014A IN2014KN01211A IN 2014KN01211 A IN2014KN01211 A IN 2014KN01211A IN 1211KON2014 A IN1211KON2014 A IN 1211KON2014A IN 2014KN01211 A IN2014KN01211 A IN 2014KN01211A
Authority
IN
India
Prior art keywords
nalmefene
hydrochloride
methylenemorphinan
cyclopropylmethyl
recovery
Prior art date
Application number
Other languages
English (en)
Inventor
Faveri Carla De
Mariano Stivanello
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014KN01211(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IN2014KN01211A publication Critical patent/IN2014KN01211A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1211KON2014 2011-12-06 2012-12-06 IN2014KN01211A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161567148P 2011-12-06 2011-12-06
DKPA201100948 2011-12-06
PCT/EP2012/074623 WO2013083685A1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride

Publications (1)

Publication Number Publication Date
IN2014KN01211A true IN2014KN01211A (es) 2015-10-16

Family

ID=48573602

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1211KON2014 IN2014KN01211A (es) 2011-12-06 2012-12-06

Country Status (32)

Country Link
US (1) US8841452B1 (es)
EP (1) EP2788357B1 (es)
JP (1) JP6086925B2 (es)
KR (1) KR20140103288A (es)
CN (1) CN104093721B (es)
AR (1) AR089080A1 (es)
AU (1) AU2012347261B2 (es)
BR (1) BR112014013541B1 (es)
CA (1) CA2857096C (es)
CL (1) CL2014001454A1 (es)
CO (1) CO6970605A2 (es)
CY (1) CY1118785T1 (es)
DK (1) DK2788357T3 (es)
ES (1) ES2622156T3 (es)
HK (1) HK1202874A1 (es)
HR (1) HRP20170497T1 (es)
HU (1) HUE033717T2 (es)
IL (1) IL232826A (es)
IN (1) IN2014KN01211A (es)
JO (1) JO3251B1 (es)
LT (1) LT2788357T (es)
ME (1) ME02668B (es)
MX (1) MX354331B (es)
PL (1) PL2788357T3 (es)
PT (1) PT2788357T (es)
RS (1) RS55817B1 (es)
RU (1) RU2631652C2 (es)
SG (1) SG11201402956UA (es)
SI (1) SI2788357T1 (es)
TW (1) TWI560170B (es)
WO (1) WO2013083685A1 (es)
ZA (1) ZA201404100B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646508B (zh) * 2016-02-17 2018-02-27 南京卓康医药科技有限公司 一种盐酸纳美芬一水合物的制备方法
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
WO2022165040A1 (en) 2021-01-28 2022-08-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577947A (en) * 1951-12-11 Manufacture of dihydrocodeinone
US3814768A (en) * 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US3896226A (en) * 1971-11-26 1975-07-22 Lewinstein Evalina 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
ATE500257T1 (de) * 1999-11-09 2011-03-15 Abbott Lab Hydromorphinonzusammensetzungen
CN1652752A (zh) * 2002-03-14 2005-08-10 欧罗赛铁克股份有限公司 盐酸纳曲酮组合物
CA2644095A1 (en) * 2006-03-02 2007-09-13 Mallinckrodt Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
JP2010511726A (ja) * 2006-12-04 2010-04-15 ノランコ・インコーポレーテツド 14−ヒドロキシコデイノンの濃度が低いオキシコドンの製造方法
WO2008094574A2 (en) 2007-01-30 2008-08-07 Biogen Idec Ma Inc. Furanone compounds and methods of making and using the same
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
MX2011012502A (es) * 2009-05-25 2011-12-12 Lundbeck & Co As H Metodo para la preparacion de hidrocloruro de nalmefeno.
CN101768164B (zh) * 2010-01-25 2011-09-14 海南数尔药物研究有限公司 一种高纯度的盐酸纳洛酮化合物

Also Published As

Publication number Publication date
PT2788357T (pt) 2017-04-24
PL2788357T3 (pl) 2017-07-31
EP2788357B1 (en) 2017-03-01
EP2788357A1 (en) 2014-10-15
CA2857096C (en) 2021-01-19
HUE033717T2 (en) 2017-12-28
AR089080A1 (es) 2014-07-30
RU2014126489A (ru) 2016-01-27
RS55817B1 (sr) 2017-08-31
MX354331B (es) 2018-02-27
MX2014006705A (es) 2014-07-09
US20140296525A1 (en) 2014-10-02
IL232826A0 (en) 2014-08-03
ME02668B (me) 2017-06-20
BR112014013541A2 (pt) 2017-06-13
AU2012347261A1 (en) 2014-06-19
TW201335110A (zh) 2013-09-01
ES2622156T3 (es) 2017-07-05
KR20140103288A (ko) 2014-08-26
US8841452B1 (en) 2014-09-23
AU2012347261B2 (en) 2016-12-01
BR112014013541B1 (pt) 2022-02-15
CN104093721A (zh) 2014-10-08
TWI560170B (en) 2016-12-01
CA2857096A1 (en) 2013-06-13
SG11201402956UA (en) 2014-07-30
CL2014001454A1 (es) 2014-10-03
JP6086925B2 (ja) 2017-03-01
CY1118785T1 (el) 2017-07-12
IL232826A (en) 2016-10-31
WO2013083685A1 (en) 2013-06-13
HRP20170497T1 (hr) 2017-06-02
SI2788357T1 (sl) 2017-06-30
LT2788357T (lt) 2017-04-25
RU2631652C2 (ru) 2017-09-26
CN104093721B (zh) 2016-05-18
JO3251B1 (ar) 2018-09-16
JP2015504856A (ja) 2015-02-16
ZA201404100B (en) 2015-11-25
HK1202874A1 (en) 2015-10-09
DK2788357T3 (en) 2017-04-24
CO6970605A2 (es) 2014-06-13

Similar Documents

Publication Publication Date Title
MX2016004406A (es) Derivados de 1,4-ciclohexilamina y proceso para la preparacion de los mismos.
TN2014000539A1 (en) Foam prevention in the reserve flotation process for purifying calcium carbonate
MX2013000793A (es) Composicion que contiene galacto-oligosacarido y un metodo para producirla.
PL2545019T3 (pl) Sposób i urządzenie do destylacyjnego otrzymywania czystego 1,3-butadienu z surowego 1,3-butadienu
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
WO2013121436A3 (en) A process for preparation of rivaroxaban and intermediates thereof
MX2011013112A (es) Solventes novedosos para la produccion de dispersiones de poliuretano.
MY194466A (en) Heterophasic polypropylene composition
IN2014KN01211A (es)
MY165487A (en) Process for preparing a polyol ether
IN2015MN00013A (es)
IN2014MN00976A (es)
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
WO2013076743A3 (en) Process for the purification of polyaminocarboxylates
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
WO2010119450A3 (en) An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
WO2013072766A3 (en) Process for cabazitaxel and intermediates thereof
EA201171413A1 (ru) Способ получения олмесартана медоксомила
IN2012DN06607A (es)
WO2013046233A3 (en) Process for the preparation of octreotide acetate
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
IN2014CN00834A (es)
WO2011132045A3 (en) Process for the preparation of dienogest substantially free of impurities
PL392036A1 (pl) Sposób odzysku renu z amoniakalnych roztworów w postaci renianu (VII) amonu wysokiej czystości
IN2013MU02793A (es)